Home › Funds › ATWOOD & PALMER INC › REGN
ATWOOD & PALMER INC position in REGN
REGENERON PHARMACEUTICALS · Health Care
ATWOOD & PALMER INC reported holding 42,454 shares of REGN (REGENERON PHARMACEUTICALS) in its Q3 2026 13F filing — a position valued at US$32.2M, representing 1.65% of its reported portfolio and ranking #27 among its reported holdings. ATWOOD & PALMER INC has disclosed REGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR
How ATWOOD & PALMER INC's REGN position evolved
ATWOOD & PALMER INC first disclosed a stake in REGN in Q3 2023 at 45,325 shares (US$37.3M). The position peaked in Q2 2024 at 43,859 shares, worth US$46.1M. Across 13 filings, ATWOOD & PALMER INC increased the stake 2 time(s), trimmed it 4 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 42,454 shares valued at US$32.2M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 45.33K | $37.30M | New |
| Q4 2023 | 44.47K | $39.06M | Reduce |
| Q1 2024 | 43.94K | $42.29M | Reduce |
| Q2 2024 | 43.86K | $46.10M | Hold |
| Q3 2024 | 43.80K | $46.04M | Hold |
| Q4 2024 | 43.68K | $31.12M | Hold |
| Q1 2025 | 41.97K | $26.62M | Reduce |
| Q2 2025 | 41.59K | $21.83M | Reduce |
| Q3 2025 | 41.43K | $23.30M | Hold |
| Q4 2025 | 41.82K | $32.28M | Add |
| Q1 2026 | 41.70K | $32.22M | Hold |
| Q2 2026 | 42.33K | $26.40M | Add |
| Q3 2026 | 42.45K | $32.19M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About REGN and 13F data
REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 31 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), LOOMIS SAYLES & CO L P (US$1.16B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding REGN
- Dodge & Cox 4.87M sh · $3.04B · Q2 2026
- DODGE & COX 4.87M sh · $3.04B · Q2 2026
- LOOMIS SAYLES & CO L P 1.86M sh · $1.16B · Q2 2026
More on ATWOOD & PALMER INC
FAQ
How long has ATWOOD & PALMER INC held REGN?
ATWOOD & PALMER INC has disclosed REGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is ATWOOD & PALMER INC's current position in REGN?
As of Q3 2026, ATWOOD & PALMER INC holds 42.45K shares of REGN (REGENERON PHARMACEUTICALS), valued at $32.19M, representing 1.65% of its reported portfolio and ranking #27.
Has ATWOOD & PALMER INC been buying or selling REGN?
In the latest 13F filing (Q3 2026), ATWOOD & PALMER INC held unchanged its position in REGN. The position peaked in Q2 2024 at 43.86K shares.
Which other funds hold REGN?
Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, LOOMIS SAYLES & CO L P, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.